In vivo peptide-based delivery of a gene-modifying enzyme into cells of the central nervous system. Academic Article uri icon

abstract

  • We report on the successful delivery of the Cre recombinase enzyme in the neural cells of mice in vivo by simple coinjection with peptides derived from HIV-TAT. Cre delivery activates the expression of a reporter gene in both neurons and astrocytes of the cortex without tissue damage and with a transduction efficiency that parallels or exceeds that of a commonly used adeno-associated virus. Our data indicate that the delivery peptides mediate efficient endosomal leakage and cytosolic escape in cells that have endocytosed Cre. The peptides, therefore, act in trans and do not require conjugation to the payload, greatly simplifying sample preparation. Moreover, the delivery peptides are exclusively composed of natural amino acids and are consequently readily degradable and processed by cells. We envision that this approach will be beneficial to applications that require the transient introduction of proteins into cells in vivo.

published proceedings

  • Sci Adv

altmetric score

  • 99.93

author list (cited authors)

  • Allen, J. K., Sutherland, T. C., Prater, A. R., Geoffroy, C. G., & Pellois, J.

citation count

  • 3

complete list of authors

  • Allen, Jason K||Sutherland, Theresa C||Prater, Austin R||Geoffroy, C├ędric G||Pellois, Jean-Philippe

publication date

  • September 2022